Pierre Fabre Laboratories Expands US Presence
Pierre Fabre Laboratories, a renowned global healthcare company originating from France, is thrilled to announce the opening of its new office, strategically located in the US. This significant move emphasizes the company’s dedication to advancing its dermo-cosmetics and medical care subsidiaries in the American market.
Strategic Growth in Dermo-Cosmetics and Medical Care
As the world’s second-largest dermo-cosmetics manufacturer, Pierre Fabre continues to innovate in oncology, cell and gene therapy, and dermatology. This expansion into the US signifies a critical juncture in their growth strategy, aimed at enhancing their footprint in dermo-cosmetics and medical care services.
Historical Background and Recent Developments
Pierre Fabre Laboratories made its mark in the US market in the 1990s with popular brands like Avène, Klorane, and René Furterer. As the demand for French dermo-cosmetics rises, the company prioritizes expanding its US operations. Building on past successes in Europe and Asia, Pierre Fabre is committed to strengthening its investments in the US medical care sector through the establishment of Pierre Fabre Pharmaceuticals (PFP). This subsidiary aims to provide groundbreaking therapies for rare diseases and oncology, focusing on underserved patient populations.
CEO Remarks on Future Potential
Eric Ducournau, CEO of Pierre Fabre Laboratories, shared his vision, stating, "We have declared the US a priority geography for the company. The vast market for pharmaceuticals and cosmetics in the US drives our innovation. Over the years, we've forged strong partnerships with innovative US biotechnology firms, especially in oncology and rare diseases. The success of our flagship brand Eau Thermale Avène has multiplied tenfold since 2010, signifying the immense potential that lies ahead. The inauguration of our office signifies our commitment to advancing our operations in rare diseases and oncology."
New Office: A Hub for Innovation
The new office in Secaucus is designed to reflect Pierre Fabre’s core values and is equipped to enhance collaboration and creativity among its teams. With excellent transportation access to New York City and the greater tri-state area, this location fosters an environment for hands-on learning and collaboration in dermatology and medical care.
Encouraging Collaboration and Patient Care
Lisa Morris, President and CEO of Pierre Fabre USA, expressed her enthusiasm about the new office, saying, "This space represents collaboration and innovation. It showcases the team's hard work and our commitment to exceeding boundaries in dermo-cosmetics and pharmaceuticals, providing new ways to care for people. This isn’t just an office; it’s a central hub for creativity and teamwork."
Commitment to Healthcare Innovations
Adriana Herrera, the CEO of PFP, echoed this sentiment, affirming that the new office demonstrates Pierre Fabre Laboratories’ commitment to fostering medical innovation and improving patient outcomes in the US. She emphasized the importance of building a robust medical care operation devoted to delivering innovative therapies to patients battling cancer, who are in dire need of effective treatments.
Looking Ahead: Plans for Continued Expansion
This expansion signifies a crucial step for Pierre Fabre Laboratories as it sets its sights on greater engagement with healthcare professionals in the US, particularly in the realms of dermo-cosmetics and pharmaceuticals. The company believes this is just the beginning of an exciting journey in transforming patient care in the country.
About Pierre Fabre Laboratories
Pierre Fabre Laboratories stands as a leading force in dermo-cosmetics and a prominent pharmaceutical entity in Europe. The company boasts an extensive portfolio, featuring esteemed brands such as Eau Thermale Avène, Ducray, Klorane, and René Furterer, focusing on therapeutic areas including oncology, dermatology, rare diseases, and family health care.
In recent years, Pierre Fabre has reported impressive revenues, with a significant portion originating from international markets. Employing over 10,200 people worldwide and investing substantially in R&D, the company is dedicated to innovative solutions that target various health issues.
Pierre Fabre operates under a unique structure where its majority shareholder is a humanitarian foundation, ensuring long-term sustainability and commitment toward improving healthcare access in underdeveloped regions.
Frequently Asked Questions
What is the significance of the new office location?
The new office in Secaucus, NJ, enhances Pierre Fabre’s accessibility to major markets and improves collaboration among teams, reflecting the company's goals in innovation.
What brands are under Pierre Fabre Laboratories?
Pierre Fabre Laboratories encompasses notable brands including Eau Thermale Avène, Klorane, Ducray, and more, primarily focusing on dermo-cosmetics.
How is Pierre Fabre contributing to patient care?
The company is focused on providing innovative therapies for chronic conditions, particularly in oncology and rare diseases, to improve patient outcomes.
What investments is Pierre Fabre making in research?
Pierre Fabre allocates a substantial budget toward R&D, dedicating significant resources to targeted therapies for oncology and skin health solutions.
How does the company ensure its corporate social responsibility?
Pierre Fabre’s CSR initiatives are structured to contribute to healthcare access programs worldwide, with a strong emphasis on sustainable practices and community support.
